The Malaysia ASEAN Point of Care Diagnostics Market was valued at $150.81 Million in 2025 and projected to reach to $187.25 Million by 2030, representing a compound annual growth rate of 4.4%. Malaysia's point of care diagnostics market is poised for sustained growth, driven by increasing healthcare spending, rising prevalence of chronic diseases, and growing consumer preference for convenient, rapid testing solutions.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Malaysia's point of care diagnostics market is valued at USD 150.81 million in 2025, with strong growth trajectory positioning it as a key market within ASEAN.
The market is expanding at a CAGR of 4.4% from 2025 to 2030, outpacing broader healthcare diagnostics trends and reflecting increasing adoption of rapid testing solutions.
Malaysia's advancing healthcare infrastructure and government initiatives to modernize diagnostic capabilities are accelerating point of care testing adoption across urban and emerging healthcare facilities.
Rising demand for rapid diagnostic solutions is driving adoption across both clinical settings (hospitals, clinics) and non-clinical environments (pharmacies, workplaces, home care), broadening market reach.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | RESPIRATORY INFECTION TESTING PRODUCTS (Disease Type) |
| Forecast Period | 2025-2030 |
| Growth Rate | CAGR of 4.7% from 2025 to 2030 |
| Largest Segment | BIOCHEMISTRY (Technology) |
| Market Size Base Year (Billions) | ~USD 1.08 (2025) |
| Revenue Forecast (Billions) | ~USD 1.36 (2030) |
| Segments Covered | Product, Type, Disease Type, Technology, End User |
5 segment dimensions are covered across the global market.
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CLINICAL LABORATORIES | 52.68 | 52.77 | 53.2 | 53.99 | 55.05 | 58.28 | 60.51 | 63.22 | 3.2 |
| HOME CARE SETTINGS | 63.31 | 64.71 | 66.6 | 69 | 71.85 | 79.41 | 84.29 | 90.05 | 5.5 |
| HOSPITALS AND CRITICAL CARE CENTERS | 14.41 | 14.61 | 14.92 | 15.34 | 15.84 | 17.23 | 18.15 | 19.23 | 4.6 |
| OTHER END USERS | 4.09 | 4.06 | 4.05 | 4.08 | 4.12 | 4.28 | 4.41 | 4.57 | 2.3 |
| OUTPATIENT SETTINGS AND AMBULATORY CARE CENTERS | 8.06 | 8.12 | 8.23 | 8.4 | 8.62 | 9.24 | 9.67 | 10.17 | 3.9 |
| TOTAL | 142.56 | 144.27 | 147 | 150.81 | 155.47 | 168.45 | 177.02 | 187.25 | 4.4 |
Malaysia's point of care diagnostics market is valued at USD 150.81 million in 2025 according to verified market data.
Malaysia's point of care diagnostics market is forecast to reach USD 187.25 million by 2030, representing a 4.4% compound annual growth rate.
Key drivers in Malaysia include rising chronic disease prevalence, an aging population, healthcare provider focus on efficiency, and government healthcare modernization initiatives.
In Malaysia, point of care diagnostics are being integrated into primary care facilities, emergency departments, clinics, and home-based testing programs.
Malaysia's 4.4% CAGR is slightly below the global ASEAN average of 4.7%, reflecting a mature but steady market with strong healthcare infrastructure.
The study involved major activities in estimating the current market size for the ASEAN point of care diagnostics market. Exhaustive secondary research was done to collect information on the ASEAN point of care diagnostics industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the ASEAN point of care diagnostics market.
The four steps involved in estimating the market size are:
In the secondary research process, various secondary sources, such as company annual reports, press releases, and investor presentations, white papers, certified publications, articles by recognized authors, gold-standard and silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva), were referred to identify and collect information for this study.
In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess prospects.
The following is a breakdown of the primary respondents:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
| COMPANY NAME | DESIGNATION |
|---|---|
| PTS Diagnostics | Regional Sales Manager |
| EKF Diagnostics Holdings plc | Product Manager |
Both top-down and bottom-up approaches were used to estimate and validate the total size of the ASEAN point of care diagnostics market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
The research methodology used to estimate the market size includes the following:

After arriving at the overall market size by applying the abovementioned process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Point of care testing (POCT) includes tests designed to be used at or near the patient's site (such as at home, in an ambulance, at a physician’s office, and other locations). POCT allows rapid & reliable diagnostic testing to obtain outcomes instantly, helping physicians/patients make care decisions remotely and rapidly.
Full forecast, segment splits, and company analysis for all ASEAN Point of Care Diagnostics Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report